Team

Team

array(10) {
  [0]=>
  string(20) "Executive Leadership"
  [1]=>
  string(23) "Chief Executive Officer"
  [2]=>
  string(24) "Senior Managing Director"
  [3]=>
  string(17) "Managing Director"
  [4]=>
  string(21) "Senior Vice President"
  [5]=>
  string(14) "Vice President"
  [6]=>
  string(16) "Senior Associate"
  [7]=>
  string(9) "Associate"
  [8]=>
  string(10) "Controller"
  [9]=>
  string(19) "Executive Assistant"
}
Adam K. Stern

Adam K. Stern

CEO, Partner

Adam K Stern is the CEO of SternAegis Ventures and has been the Head of Private Equity Banking at Aegis Capital Corp since 2012. Prior to SternAegis, from 1997 to 2012, he was Senior Managing Director at Spencer Trask Ventures, Inc., where he managed the structured finance group focusing primarily on technology and life science companies. From 1989 to 1997, Mr Stern was at Josephthal & Co., Inc., Members of the New York Stock Exchange, where he served as Head of Private Equity and Managing Director. He has been a FINRA licensed securities broker since 1987 and a Registered General Securities Principal since 1991.

Mr. Stern has been a founding investor in numerous private and public companies and currently serves as a Director of DarioHealth Corp. (Nasdaq: DRIO), Matinas BioPharma Holdings, Inc. (NYSE: MTNB), and Aerami Therapeutics, Inc.

Mr. Stern graduated from the Lear School, Miami Florida in 1982 and The University of South Florida in 1987.

Daniel Seto, CFA

Daniel Seto, CFA

Senior Managing Director

Daniel Seto joined Aegis Capital Corp. in September 2016 as Managing Director of SternAegis Ventures and Private Equity Banking at Aegis Capital.

Mr. Seto has approximately 20 years of experience in the financial services industry across investment banking, portfolio management, and equity research. Previously, he was Senior Vice President at ArcLight Advisors LLC providing investment banking and business development services focused on healthcare companies. Prior to that, he was Vice-President in investment banking at Ledgemont Capital Group.

From 2004-2008, Mr. Seto was a Portfolio Manager for Wheaten Capital Management LLC, a long/short equity healthcare hedge fund. As Portfolio Manager, Mr. Seto invested in both public and private companies across all subsectors of healthcare, including pharmaceuticals, biotechnology, medical technology, life science tools, and healthcare services. From 1999-2003, Mr. Seto was an equity analyst at Bank of America Securities covering the Specialty Pharmaceuticals industry. Mr. Seto started his career in equity research at UBS covering the Specialty Pharmaceuticals industry.

Mr. Seto's academic credentials include designation as a Chartered Financial Analyst and a B.A. in Economics from the University of Michigan.

Viren Desai, MD

Viren Desai, MD

Senior Managing Director

Dr. Desai joined Aegis Capital Corp. and Stern Aegis Ventures as a Senior Managing Director in October, 2022.  Dr. Desai has operational experience in medical markets, investment banking, and venture capital. 

Dr. Viren Desai is a Licensed Investment Banking  Professional, Investor, and Seasoned Physician with 30 years of experience, which includes leading a successful private healthcare practice and strategizing with healthcare-related practices to combine operations or create multispecialty practices.  Dr. Desai is a board-certified Cardio-Thoracic Anesthesiologist trained at Emory University Medical Center and Vanderbilt University Medical Center.  He has participated on multiple advisory councils and boards and successfully developed a pain management business, which he profitably exited via a private equity buyout.  He is experienced in operational efficiency, marketing, and financial oversight. 

Dr. Desai’s main interest lies within private equity funding and investing in Biotech, Pharma, Life-Sciences, and Healthcare businesses. He evaluates new investments and deal sourcing activities and provides business and operational support to portfolio companies.  He holds FINRA series 63 and 79 licenses

Michael Siek

Michael Siek

Managing Director

Phone: (212) 776-1848

Michael Siek joined Aegis Capital Corp. and SternAegis Ventures as Senior Managing Director.

Mr. Siek has over 25 years of experience providing specialty financing and human capital advice regarding emerging private and public companies. Previously, he was President of Spencer Trask Ventures, where he spent 18 years of his career. During his tenure with Spencer Trask, he has raised more than a quarter billion dollars for over 75 of Spencer Trask's portfolio companies, ranging in industries from medical and biotechnologies to SaaS Software and IT services. 

Mr. Siek started his career at Lehman Brothers and is currently registered with General Securities, Principle/Supervisor and State Securities licenses. He is a graduate of Rollins College and holds a B.A. in Economics and Business, and lives in Rowayton, CT.

Larry Cohen

Larry Cohen

Managing Director

Phone: (646) 502-2460

Larry Cohen. Managing Director of Private Equity Investment Banking. Mr. Cohen joined the Firm in May of 2018, he brings close to 20years of Investment banking and capital raising experience. Specializing in the Healthcare sector including  Bio-Tech, Pharma, Medical Device and Technology.

Mr. Cohen began his career at Lehman Brothers in the late 90’s, where he was part of the Hedge Fund and Banking Group.

He is a FINRA registered representative with a series 7 and 63.   

John Russo

John Russo

Managing Director

Phone: (646) 502-2520

John Russo, Managing Director of Private Equity Investment Banking, Joined the firm June in 2018.  Mr. Russo has passed the Series 7,66,55,24 Finra exams.  He has worked in trading and business development capacities at firms such as Goldman Sachs, Merrill Lynch and JPMorgan Chase. 

For the last 5 years John has worked in private equity, specializing in fundraising in the life science and technology sectors.

 John is a Certified Retirement Plan Consultant.

John Clarke

John Clarke

Managing Director

John Clarke joined Aegis Capital Corp. and SternAegis Ventures as Senior Managing Director.

Mr. Clarke has over 35 years of experience providing specialty financing and capital advice regarding emerging private and public companies. Previously, he has been President of H.C. Wainwright & Co and worked with Spencer Trask Ventures, as well as several Investment boutiques and NYSE brokerage firms. During his career, he has raised several hundred million dollars for over 100 private and public Offerings in a variety of emerging industries. 

Mr. Clarke developed his career as a Branch Manager for Josepthal, Lyon & Ross and is currently registered with Representative, General Securities and Financial and Operations Principal Securities licenses. He is a graduate of the E. Claiborne Robbins School of Business and holds a B.S. in Finance, and lives in New Jersey.

Jamie Polak

Jamie Polak

Controller

Jamie Polak joined Aegis Capital Corp. in October 2012 as a Vice President of Wealth Management and Insurance. Mr. Polak has extensive experience in financial modeling, securities valuation, asset allocation, and risk management.

Since 2007, Mr. Polak has worked as a research analyst for the hedge fund RL Capital partners, a multi-strategy growth hedge fund. At RL Capital, Mr. Polak focused on investment analysis and portfolio management, with an emphasis on small and mid-cap biotechnology companies.

Mr. Polak is also a general partner of a venture capital fund called Domaco Venture Capital Fund, focusing on private placement investments and fund administration.

Prior to Aegis, Mr. Polak was previously with Maxim Group, where he focused his research on small to mid-cap U.S. listed equities. He also worked as a multimedia producer for Bloomberg L.P., providing analysis and reporting for the Bloomberg terminals. Mr. Polak started his career as an Equity Research Associate for Gruntal & Co. L.L.C., specializing in Internet Software and Biotechnology companies in the early 2000s. Mr. Polak holds a BBA from the George Washington University and an MBA from the Smith School of Business at the University of Maryland. He is a CERTIFIED FINANCIAL PLANNER™ and holds FINRA series 7, 63, 24, and 16 licenses.

John Cutrone, CFA

John Cutrone, CFA

Managing Director

Phone: (646) 502-2551

John Cutrone, Managing Director of Private Equity Investment Banking, joined SternAegis Ventures and Aegis Capital in September 2017. Mr. Cutrone brings international experience in asset management, banking, and private equity.

From 2014 to 2017 Mr. Cutrone was employed at W.P. Carey, a $24B private equity manager. Prior to that, he rose from Healthcare Analyst to Asset Management Senior Associate at Bank of New York Mellon from 2010 to 2014.

Mr. Cutrone is a CFA Charterholder and holds FINRA 7 and 63 licenses. He graduated from the Gabelli School of Business, Roger Williams University. He is an active member of CFA Society New York Young Leaders group and Big Brothers Big Sisters of America.

Nicholas Petracca

Nicholas Petracca

Senior Associate

Nicholas Petracca joined Aegis Capital Corp. in 2015. 

From 2013 until 2015, Mr. Petracca was an Analyst at Triangle Equities, a full-service real estate development firm in New York City.

Mr. Petracca received a B.A. in Political Science from Denison University in 2013.

Edward Shadek

Edward Shadek

Senior Associate

Edward Shadek joined Aegis Capital Corp. in 2018.

Mr. Shadek received an B.A. in Economics from Wesleyan University in 2018.

Samuel Milbury

Samuel Milbury

Associate


Samuel Milbury joined Aegis Capital Corp. in 2019.

From 2017 until 2019, Mr. Milbury was a Senior Analyst at Chatham Partners, a market research and strategy consulting firm in Boston.

Mr. Milbury received a B.A. in Economics from Trinity College in Hartford in 2017.

William Shadek

William Shadek

Associate

William Shadek joined Aegis Capital Corp. in 2019.

Mr. Shadek received a B.A. in History from Dartmouth College in 2019.

Jordan Hurwitz

Jordan Hurwitz

Associate

Jordan Hurwitz joined SternAegis and Aegis Capital Corp. in May 2017.

Mr. Hurwitz received a B.A. in Telecommunications/Entrepreneurship Innovation from the Pennsylvania State University.

John Allen

John Allen

Associate

John Allen joined Aegis Capital Corp in 2019. 

John received a BA in Operations and Information Management from the Isenberg School of Management at the University of Massachusetts Amherst in 2020.

Zachary Stern

Zachary Stern

Associate

Zachary Stern joined SternAegis in 2021.  

Mr. Stern received a B.A. in Economics from Syracuse University in 2021.  

Brokerage and investment advisory products and services, are offered through Aegis Capital Corp, a member of FINRA and SIPC. Insurance products are made available through, ACC General Agency, a licensed insurance agency. For those persons inquiring from states where a specific associate is not currently securities and/or insurance licensed, the associate will not transact business in that state or provide follow-up individual responses, until after the associate obtains the appropriate registration in the applicable state.

The information provided should not be relied upon in isolation for the purpose of making an investment decision. You must also consider the objectives, risks, charges, and expenses associated with an investment service, product or strategy prior to making an investment decision. Prior to making any investment or financial decision, an investor should seek advice from a financial, legal, tax and other professional that consider all of the particular facts and circumstances of an investor's situation. The opinions expressed and material provided are for information purposes only and is not an offer, recommendation, or solicitation of any product, strategy or transaction. Any views, strategies or products discussed may not be appropriate or suitable for all individuals and are subject to risks.

Investment and insurance products offered are not insured by the FDIC or any other federal government agency, are not deposits or other obligations of, or guaranteed by, a bank or any bank affiliate, and are subject to investment risks, including possible loss of the principal amount invested.

Check the background of your financial professional on FINRA's BrokerCheck

Form CRS and General Disclosures

Aegis Risk Disclosures